Search results for "Imipramine"

showing 10 items of 37 documents

Optimised procedures for the reversed-phase liquid chromatographic analysis of formulations containing tricyclic antidepressants.

2003

The chromatographic behaviour (retention, selectivity, peak shape and resolution) of seven tricyclic antidepressants (TCAs), amitryptiline, clomipramine, doxepin, imipramine, maprotiline, nortryptiline and trimipramine, was examined. Conventional unendcapped Cs and C18 columns and an endcapped XTerra MS C18 column recommended for the analysis of basic compounds were used together with acetonitrile-water and micellar sodium dodecylsulfate (SDS)-pentanol mobile phases. The two best combinations were XTerra C18/acetonitrile, which yielded the largest efficiencies and resolution, and C8/SDS-pentanol, which eliminated the peak tails that were still observed with the XTerra C18 column. Both the s…

AcetonitrilesResolution (mass spectrometry)Clinical BiochemistryPharmaceutical ScienceCapsulesAntidepressive Agents TricyclicSensitivity and SpecificityDosage formAnalytical Chemistrychemistry.chemical_compoundDrug DiscoverymedicineAcetonitrileSpectroscopyChromatography High Pressure LiquidChromatographyExtraction (chemistry)Reproducibility of ResultsReversed-phase chromatographyDoxepinTrimipraminechemistry1-PentanolSolventsmedicine.drugTabletsJournal of pharmaceutical and biomedical analysis
researchProduct

Is the nonREM–REM sleep cycle reset by forced awakenings from REM sleep?

2002

In selective REM sleep deprivation (SRSD), the occurrence of stage REM is repeatedly interrupted by short awakenings. Typically, the interventions aggregate in clusters resembling the REM episodes in undisturbed sleep. This salient phenomenon can easily be explained if the nonREM–REM sleep process is continued during the periods of forced wakefulness. However, earlier studies have alternatively suggested that awakenings from sleep might rather discontinue and reset the ultradian process. Theoretically, the two explanations predict a different distribution of REM episode duration. We evaluated 117 SRSD treatment nights recorded from 14 depressive inpatients receiving low dosages of Trimipram…

Activity CyclesMaleSelective REM sleep deprivationPolysomnographyAudiologyBehavioral NeuroscienceNIGHTSleep onset REM episodeDEPRIVATIONSlow-wave sleepmedia_commonDEPRESSIVE PATIENTSmedicine.diagnostic_testDepressionmusculoskeletal neural and ocular physiologyTRIMIPRAMINEMiddle AgedAntidepressive AgentsAnesthesiaLATENCIESFemaleWakefulnessArousalPsychologyAlgorithmspsychological phenomena and processesmedicine.drugVigilance (psychology)Adultmedicine.medical_specialtyREM episodePolysomnographymedia_common.quotation_subjectRapid eye movement sleepSleep REMExperimental and Cognitive PsychologyNon-rapid eye movement sleepmental disordersmedicineHumansWakefulnessMODULATIONUltradian rhythmINTERRUPTIONARTIFICIAL NEURAL NETWORKSRECOGNITIONTrimipramineUltradian processSleep cycleSleepEYE-MOVEMENT SLEEPPhysiology & Behavior
researchProduct

Center differences and cross-national invariance in help-seeking for panic disorder. A report from the cross-national collaborative panic study.

1992

Help-seeking behaviour for treatment of panic disorder was investigated in the sample of the Cross-National Collaborative Panic Study Second Phase. A total of 1168 patients were entered into this trial in 14 countries. Although there were significant center differences in prior treatment and utilization of health services there were also similarities. Treatment had been provided mainly by general practitioners. Drug treatment consisted mostly of prescription of classical tranquilizers and had a longer duration than treatment by psychotherapy. Patients with agoraphobic avoidance, past major depression and longer duration of illness used medical and psychiatric treatment facilities more inten…

AdultCross-Cultural ComparisonMalemedicine.medical_specialtyImipramineHealth (social science)Social PsychologyEpidemiologyPharmacotherapyEpidemiologymedicineHumansMedical prescriptionPsychiatryDepression (differential diagnoses)Alprazolambusiness.industryPanic disorderIncidencePanicPatient Acceptance of Health Caremedicine.diseaseHelp-seekingPsychiatry and Mental healthCross-Sectional StudiesPanic DisorderFemalemedicine.symptombusinessAnxiety disorderClinical psychologySocial psychiatry and psychiatric epidemiology
researchProduct

Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo

1994

Summary Side effects play a significant role in the selection of drugs to be used in panic disorder/agoraphobia whose polyphobic symptomatology often includes a suspiciousness about taking drugs and a fear of undesired side effects which may lead to the refusal of treatment. The safety, side effects and patients' acceptance of alprazolam and imipramine versus placebo were evaluated in 1168 subjects with panic disorder/agoraphobia who had been enrolled in the second phase of the Upjohn World Wide Panic Study. Side effects that worsened over baseline to a greater extent with alprazolam than with imipramine and placebo were sedation, fatigue/weakness, memory problems, ataxia and slurred speech…

AdultImipramineAdolescentSide effectPoison controlPlaceboImipramineDouble-Blind MethodmedicineHumansPharmacology (medical)Biological PsychiatryAgedPsychiatric Status Rating ScalesPharmacologyAlprazolambusiness.industryPanic disorderPanicMiddle Agedmedicine.diseasePsychiatry and Mental healthNeurologyAlprazolamAnesthesiaPanic DisorderPatient ComplianceNeurology (clinical)medicine.symptombusinessAgoraphobiamedicine.drugEuropean Neuropsychopharmacology
researchProduct

Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients.

1993

Bidirectional drug interactions between fluvoxamine and classical antidepressants were studied in depressed patients. A column switching technique combined with high performance liquid chromatography (HPLC) enabled automated analyses of plasma for simultaneous determination of fluvoxamine, tricyclic and tetracyclic antidepressants and demethylated and major hydroxylated metabolites in a single HPLC run. The measurements revealed that fluvoxamine inhibited N-demethylation of imipramine, clomipramine, amitriptyline and maprotiline whereas interferences with hydroxylation reactions were restricted to aromatic 8-hydroxylation of clomipramine. In patients under fluvoxamine monotherapy before com…

AdultMaleClomipraminemedicine.drug_classTricyclic antidepressantFluvoxaminePharmacologyHydroxylationImipraminemedicineHumansAmitriptylineMaprotilineChromatography High Pressure LiquidPharmacologychemistry.chemical_classificationDepressive DisorderChemistryMiddle AgedAntidepressive AgentsDealkylationFluvoxamineAntidepressantFemaleSpectrophotometry Ultravioletmedicine.drugTricyclicPsychopharmacology
researchProduct

A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.

1996

A double-blind, randomized, parallel study in 167 hospitalized patients with major depression and melancholia was conducted to determine if rapidly escalated doses of venlafaxine produced an earlier response, compared with rapidly escalated doses of imipramine. The daily dose of venlafaxine was rapidly increased to 375 mg/day over a five-day period, was maintained at this level for 10 days, and then was reduced to 150 mg/day for the remainder of the study. The imipramine dose was rapidly increased to 200 mg/day over five days and was maintained at this level to the end of the study. The primary efficacy variables were time to response and time to sustained response on the HAM-D and MADRS. N…

AdultMaleImipraminePersonality Inventorymedicine.medical_treatmentVenlafaxineAntidepressive Agents TricyclicImipramineDrug Administration ScheduleDouble blindDouble-Blind MethodMelancholiamedicineHumansBiological PsychiatryDepression (differential diagnoses)Rapid responseChemotherapyDepressive DisorderDose-Response Relationship DrugVenlafaxine HydrochlorideParallel studyMiddle AgedCyclohexanolsPsychiatry and Mental healthTreatment OutcomeAnesthesiaAntidepressive Agents Second-GenerationFemalemedicine.symptomPsychologymedicine.drugJournal of psychiatric research
researchProduct

Subchronic Antidepressant Treatment with Venlafaxine or Imipramine and Effects on Blood Pressure and Heart Rate: Assessment by Automatic 24-Hour Moni…

1996

Venlafaxine is a new nontricyclic antidepressant inhibiting the reuptake of serotonin, noradrenaline, and, to a lesser extent, dopamine without antagonizing cholinergic, histaminergic, or noradrenergic receptors. Significantly, in a first placebo-controlled safety and efficacy study, high doses of venlafaxine increased blood pressure in some study subjects. In order to investigate further the effect of subchronic antidepressant drug treatment on blood pressure and heart rate, the effects of a conventional tricyclic (imipramine) and a structurally different phenethylamine antidepressant (venlafaxine) were compared. Sixteen inpatients with major depression (melancholic type) were treated for …

AdultMaleImipramineVenlafaxine HydrochlorideHemodynamicsBlood PressureVenlafaxineAntidepressive Agents TricyclicImipramineDouble-Blind MethodHeart RateHeart ratemedicineHumansPharmacology (medical)Psychiatric Status Rating ScalesDepressive Disorderbusiness.industryVenlafaxine HydrochlorideGeneral MedicineBlood Pressure Monitoring AmbulatoryMiddle AgedCyclohexanolsPsychiatry and Mental healthBlood pressureAnesthesiaCirculatory systemAntidepressive Agents Second-GenerationAntidepressantFemalebusinessmedicine.drugPharmacopsychiatry
researchProduct

Drug treatment of panic disorder: early response to treatment as a predictor of final outcome

1990

One of the core problems in clinical research is the detection of early changes in target symptoms that predict future therapeutic outcome. To analyze potential predictors of outcome, data of a multicenter study on patients with panic disorder were used. A total of 1010 patients were randomly allocated either to alprazolam, imipramine or placebo treatment. Early improvement in the number of spontaneous panic attacks within the first week of treatment predicted outcome exclusively in the alprazolam group. In contrast, placebo responders and nonresponders were differentiated by early changes in anticipatory anxiety intensity. For tricyclic antidepressants such as imipramine an evaluation peri…

AdultMaleImipraminemedicine.medical_specialtyPlaceboImipramineDouble-Blind MethodInternal medicinemedicineHumansPsychiatryAgoraphobiaPsychiatric Status Rating Scaleschemistry.chemical_classificationAlprazolamPanic disorderPanicmedicine.diseaseAnxiety DisordersPanicPsychiatry and Mental healthClinical researchchemistryAlprazolamAnxietyFemalemedicine.symptomArousalPsychologyTricyclicmedicine.drugActa Psychiatrica Scandinavica
researchProduct

Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment

1991

In order to establish the clinical validity of currently used ways of subtyping panic disorder the predictive power of associated current avoidance behaviour and (secondary) major depression for the response to active treatment (alprazolam, imipramine) was tested. The analysis was based on the data from the Cross-National-Collaborative-Panic-Study. Limited support for validity evidenced by predicting drug response was found for grading panic disorder by the severity of avoidance behaviour; patients with panic attacks and agoraphobia are more responsive to imipramine (compared with alprazolam) when using the reduction of the total number of panic attacks (or of spontaneous panic attacks) as …

AdultMaleImipraminemedicine.medical_specialtySocial Environmentbehavioral disciplines and activitiesImipraminelaw.inventionDouble-Blind MethodRandomized controlled triallawmental disordersmedicineHumansPharmacology (medical)PsychiatryAgoraphobiaBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesDepressive DisorderAlprazolamPanic disorderPanicGeneral MedicinePrognosismedicine.diseaseAnxiety DisordersPanichumanitiesSubtypingPsychiatry and Mental healthAlprazolamFemalemedicine.symptomPsychologymedicine.drugAgoraphobiaClinical psychologyEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

Influence of St John's wort on catecholamine turnover and cardiovascular regulation in humans

2004

BACKGROUND: St John's wort (Hypericum perforatum) is a popular over-the-counter antidepressant. Its antidepressive effect has been attributed in part to inhibition of monoamine transporters and monoamine oxidase, on the basis of in vitro studies. METHODS: In a double-blind, randomized, placebo-controlled, crossover study, 16 healthy subjects (11 men and 5 women; mean age, 31 +/- 5 years) ingested either St John's wort (300 mg three times daily) or placebo for 7 days. Imipramine treatment (50 mg three times daily) in 7 subjects served as a positive control. After treatment, physiologic and biochemical tests included cardiovascular reflex testing, graded head-up tilt testing, and plasma catec…

AdultMaleNitroprussideImipraminemedicine.medical_specialtyPosturePharmacologyAutonomic Nervous SystemPlaceboMethoxyhydroxyphenylglycolNorepinephrine uptakeCardiovascular Physiological PhenomenaNorepinephrineCatecholaminesDouble-Blind MethodInternal medicineHeart rateSupine PositionmedicineHumansNitric Oxide DonorsPharmacology (medical)PeryleneAnthracenesPharmacologyCross-Over StudiesAdrenergic Uptake Inhibitorsbusiness.industryHemodynamicsHypericum perforatumEndocrinologyBlood pressureMonoamine neurotransmitterCatecholamine34-Dihydroxyphenylacetic AcidAntidepressantFemalebusinessHypericummedicine.drugClinical Pharmacology & Therapeutics
researchProduct